secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCorRx Inc. (BICX)
CIK:        0001443863
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001477932-26-001957
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCorRx acquires additional 12.15% of subsidiary via stock-for-stock exchange with insiders
--------------------------------------------------------------------------------

- Entered stock exchange agreement with CEO, President, and board member to transfer 1,215 subsidiary shares for 2,263,371 parent shares.
- Exchange closed March 27, 2026; intended as tax-free reorganization under Section 368(a)(1)(B).
- Subsidiary BioCorRx Pharmaceuticals was ~12.15% minority stake acquired; no cash consideration paid.
- Parent shares are unregistered, issued under Section 4(a)(2) exemption; registration rights granted to shareholders.
- Part of Plan of Reorganization to obtain control of subsidiary under Section 368(c) of the Code.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1443863/000147793226001957/0001477932-26-001957-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1443863/000147793226001957/bicx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-001957

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer